How much funding has Kardigan raised?

Kardigan has raised $554.0M in total funding, most recently a Series B round.

Who are Kardigan's investors?

Kardigan's investors include ARCH Venture Partners, Sequoia Heritage, Fidelity Management, T. Rowe Price, Perceptive Advisors.

Where is Kardigan headquartered?

Kardigan is headquartered in South San Francisco, California, United States.

What industry is Kardigan in?

Kardigan operates in Biotech, Healthcare.

Kardigan

IPO

Cardiovascular Drug Development for Heart Health

South San Francisco, United States · Founded 2023 · $554.0M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 51–200
Founded: 2023
Business Model: B2B

Website: kardigan.bio
Total Funding: $554.0M
Last Round: $254.0M Series BOct 2025
Rounds: 2

About

Kardigan is a heart health company modernizing cardiovascular drug development with a late-stage pipeline targeting genetic dilated cardiomyopathy, calcific aortic valve stenosis, and acute severe hypertension. Founded in 2023 by MyoKardia veterans, Kardigan integrates AI-driven real-world data from its Prolaio platform to accelerate clinical programs and develop therapies aimed at curing rather than merely managing cardiovascular disease.

Summary

Kardigan is a Biotech company based in South San Francisco, United States, founded in 2023. It has raised $554.0M in total across 2 rounds, most recently a $254.0M Series B round in Oct 2025. Investors include ARCH Venture Partners, Sequoia Heritage and Fidelity Management.